go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Sanofi Pharma Bristol-Myers Squibb SNC
174 avenue de France, F-75013 Paris, , France
Telephone: +353 1 403 5600 - Plavix
Telephone: +353 1 291 3800 - Aprovel and Co-Aprovel
Fax: +353 1 291 3899 - Aprovel and Co-Aprovel
Fax: +353 1 403 5687 - Plavix
Medical Information Direct Line: Freephone: 1 800 749 749 - Aprovel and Co-Aprovel
Medical Information e-mail: medical.information@bms.com - Aprovel and Co-Aprov
Medical Information e-mail: IEmedinfo@sanofi-aventis.com - Plavix
Medical Information Facsimile: +44 (0)1895 523 677 - Aprovel and Co-Aprovel
Patient Information Leaflet last updated on medicines.ie: 15/09/2011
PIL CoAprovel 150/12.5 mg, 300/12.5 mg and 300/25 mg Film-Coated Tablets (Sanofi Pharma Bristol-Myers Squibb SNC)

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 15/09/2011 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 10/06/2011 and displayed until 15/09/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 26/02/2007 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to date of revision
  • Joint PIL superseded by PILs for individual presentations
Updated on 21/11/2006 and displayed until 26/02/2007
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Hydrochlorothiazide
  Irbesartan